Clinical Trial Update: Multi-centric Study [Phase 2]

View source ↗

Summary

Phase 2 multi-center trial in B-cell acute lymphoblastic leukemia with refractory disease and CD22+ expression has completed; sponsored by Nantes University Hos…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• B-cell Acute Lymphoblastic Leukemia

Snippet

Sponsor: Nantes University Hospital | Conditions: B ALL, CD22+ Expression | Phase 2 | Status: COMPLETED